{"transactions":[{"id":834211,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:30:29.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":5251,"price":0.19,"value":997.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,700 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":331338,"source":{"system":"sec-edgar","filing":"0001477932-26-001491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001491/form4.xml","form_type":"4"}},{"id":834209,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2026-03-19T20:30:28.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3948,"price":0.19,"value":750.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,400 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":273993,"source":{"system":"sec-edgar","filing":"0001477932-26-001490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001490/form4.xml","form_type":"4"}},{"id":834210,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:30:18.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":5310,"price":0.19,"value":1008.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,800 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":572179,"source":{"system":"sec-edgar","filing":"0001477932-26-001488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001488/form4.xml","form_type":"4"}},{"id":834208,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2026-03-19T20:30:11.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":7003,"price":0.19,"value":1330.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 14,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":407267,"source":{"system":"sec-edgar","filing":"0001477932-26-001489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001489/form4.xml","form_type":"4"}},{"id":872531,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2026-03-03T21:31:18.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3321,"price":0.213,"value":707.373,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,908 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":277941,"source":{"system":"sec-edgar","filing":"0001477932-26-001147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001147/form4.xml","form_type":"4"}},{"id":872529,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:30:33.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2283,"price":0.213,"value":486.279,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 5,523 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.\nNo shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":336589,"source":{"system":"sec-edgar","filing":"0001477932-26-001146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001146/form4.xml","form_type":"4"}},{"id":872528,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2026-03-03T21:30:25.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5867,"price":0.213,"value":1249.671,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":414270,"source":{"system":"sec-edgar","filing":"0001477932-26-001145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001145/form4.xml","form_type":"4"}},{"id":878861,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:32:34.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":149000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 149,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":338872,"source":{"system":"sec-edgar","filing":"0001477932-26-001105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001105/form4.xml","form_type":"4"}},{"id":878862,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64387,"kind":"person","name":"Rubin Ethel","position":1,"cik":"0002038290","reported_name":"Rubin Ethel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:32:24.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date."}],"balance_after":252948,"source":{"system":"sec-edgar","filing":"0001477932-26-001104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001104/form4.xml","form_type":"4"}},{"id":878860,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-27T21:32:03.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":486000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 486,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":3115547,"source":{"system":"sec-edgar","filing":"0001477932-26-001103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001103/form4.xml","form_type":"4"}},{"id":878859,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:31:45.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":142000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 142,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date."}],"balance_after":324072,"source":{"system":"sec-edgar","filing":"0001477932-26-001102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001102/form4.xml","form_type":"4"}},{"id":878858,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:31:36.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":202000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 202,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":684970,"source":{"system":"sec-edgar","filing":"0001477932-26-001101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001101/form4.xml","form_type":"4"}},{"id":878857,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2026-02-27T21:31:25.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":119000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 119,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":281262,"source":{"system":"sec-edgar","filing":"0001477932-26-001100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001100/form4.xml","form_type":"4"}},{"id":878854,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2026-02-27T21:31:16.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":187000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 187,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":420137,"source":{"system":"sec-edgar","filing":"0001477932-26-001099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001099/form4.xml","form_type":"4"}},{"id":878856,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64383,"kind":"person","name":"Nguyen Kim","position":1,"cik":"0001852492","reported_name":"Nguyen Kim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:31:06.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":305816,"source":{"system":"sec-edgar","filing":"0001477932-26-001098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001098/form4.xml","form_type":"4"}},{"id":878855,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2026-02-27T21:30:58.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":173000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 173,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":418614,"source":{"system":"sec-edgar","filing":"0001477932-26-001097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001097/form4.xml","form_type":"4"}},{"id":878852,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:30:44.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":149000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 149,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":577489,"source":{"system":"sec-edgar","filing":"0001477932-26-001096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001096/form4.xml","form_type":"4"}},{"id":878853,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:30:29.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":1252967,"source":{"system":"sec-edgar","filing":"0001477932-26-001095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001095/form4.xml","form_type":"4"}},{"id":923892,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:05:22.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2010,"price":0.285,"value":572.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 4,863 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":189872,"source":{"system":"sec-edgar","filing":"0001477932-26-000607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000607/form4.xml","form_type":"4"}},{"id":923891,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2026-02-03T21:05:11.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3196,"price":0.285,"value":910.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,611 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":162262,"source":{"system":"sec-edgar","filing":"0001477932-26-000606","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000606/form4.xml","form_type":"4"}},{"id":923890,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2026-02-03T21:05:05.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5647,"price":0.285,"value":1609.395,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,015 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":233137,"source":{"system":"sec-edgar","filing":"0001477932-26-000605","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000605/form4.xml","form_type":"4"}},{"id":932904,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64387,"kind":"person","name":"Rubin Ethel","position":1,"cik":"0002038290","reported_name":"Rubin Ethel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:08:46.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":74948,"source":{"system":"sec-edgar","filing":"0001477932-26-000373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000373/form4.xml","form_type":"4"}},{"id":932905,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:08:33.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":1074967,"source":{"system":"sec-edgar","filing":"0001477932-26-000372","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000372/form4.xml","form_type":"4"}},{"id":932903,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:08:20.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":38100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 127,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 38,100 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 12,700 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 88,900 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":191882,"source":{"system":"sec-edgar","filing":"0001477932-26-000371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000371/form4.xml","form_type":"4"}},{"id":932902,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-23T21:08:07.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":74700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 249,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 74,700 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 24,900 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 174,300 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":2629547,"source":{"system":"sec-edgar","filing":"0001477932-26-000370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000370/form4.xml","form_type":"4"}},{"id":932901,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68972,"kind":"person","name":"Colman Alan","position":1,"cik":"0001577873","reported_name":"Colman Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:07:35.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":257364,"source":{"system":"sec-edgar","filing":"0001477932-26-000369","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000369/form4.xml","form_type":"4"}},{"id":932899,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68971,"kind":"person","name":"STILL TIMOTHY I","position":1,"cik":"0001200616","reported_name":"STILL TIMOTHY I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:07:25.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 300,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 90,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 30,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 210,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":1625458,"source":{"system":"sec-edgar","filing":"0001477932-26-000368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000368/form4.xml","form_type":"4"}},{"id":932900,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:07:09.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":33900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 113,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 33,900 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,300 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 79,100 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":182072,"source":{"system":"sec-edgar","filing":"0001477932-26-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000367/form4.xml","form_type":"4"}},{"id":932898,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:55.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":49200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 164,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 49,200 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 16,400 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 114,800 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":482970,"source":{"system":"sec-edgar","filing":"0001477932-26-000366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000366/form4.xml","form_type":"4"}},{"id":932896,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68970,"kind":"person","name":"Barnes Phillip","position":1,"cik":"0001790293","reported_name":"Barnes Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:06:44.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":67368,"source":{"system":"sec-edgar","filing":"0001477932-26-000365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000365/form4.xml","form_type":"4"}},{"id":932895,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":53400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 178,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 53,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 17,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 124,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":375203,"source":{"system":"sec-edgar","filing":"0001477932-26-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000364/form4.xml","form_type":"4"}},{"id":932894,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:20.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":28200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 94,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,200 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,400 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 65,800 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":165458,"source":{"system":"sec-edgar","filing":"0001477932-26-000363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000363/form4.xml","form_type":"4"}},{"id":932897,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:10.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 118,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 35,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 82,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":428489,"source":{"system":"sec-edgar","filing":"0001477932-26-000362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000362/form4.xml","form_type":"4"}},{"id":932892,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:52.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 149,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 44,700 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,900 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 104,300 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":238784,"source":{"system":"sec-edgar","filing":"0001477932-26-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000361/form4.xml","form_type":"4"}},{"id":932893,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68968,"kind":"person","name":"Henshall Mickie","position":1,"cik":"0001939342","reported_name":"Henshall Mickie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:05:43.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":44206,"source":{"system":"sec-edgar","filing":"0001477932-26-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000360/form4.xml","form_type":"4"}},{"id":932891,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64383,"kind":"person","name":"Nguyen Kim","position":1,"cik":"0001852492","reported_name":"Nguyen Kim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T21:05:30.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":127816,"source":{"system":"sec-edgar","filing":"0001477932-26-000359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000359/form4.xml","form_type":"4"}},{"id":932890,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:22.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 140,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 42,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 98,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":245614,"source":{"system":"sec-edgar","filing":"0001477932-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000358/form4.xml","form_type":"4"}},{"id":998471,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-17T18:12:19.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.35,"value":7000.0,"ownership":{"direct":true},"balance_after":2554847,"source":{"system":"sec-edgar","filing":"0001477932-25-008380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225008380/form4.xml","form_type":"4"}},{"id":1009208,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:54.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4588,"price":0.434,"value":1991.192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,762 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":146568,"source":{"system":"sec-edgar","filing":"0001477932-25-007902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007902/form4.xml","form_type":"4"}},{"id":1009206,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:42.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5647,"price":0.434,"value":2450.798,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,016 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":194084,"source":{"system":"sec-edgar","filing":"0001477932-25-007901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007901/form4.xml","form_type":"4"}},{"id":1009207,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:37.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3197,"price":0.434,"value":1387.498,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,612 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":137258,"source":{"system":"sec-edgar","filing":"0001477932-25-007900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007900/form4.xml","form_type":"4"}},{"id":1009203,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:21.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4648,"price":0.434,"value":2017.232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,996 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":321803,"source":{"system":"sec-edgar","filing":"0001477932-25-007899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007899/form4.xml","form_type":"4"}},{"id":1009205,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:07.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1753,"price":0.434,"value":760.802,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 4,864 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":153782,"source":{"system":"sec-edgar","filing":"0001477932-25-007898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007898/form4.xml","form_type":"4"}},{"id":1018954,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant (Right to Buy)","published_at":"2025-10-15T20:05:45.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":110000,"price":0.01,"value":1100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer.  The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":110000,"derivative":{"exercise_price":0.6,"exercise_date":"2025-10-14","expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001477932-25-007588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007588/form4.xml","form_type":"4"}},{"id":1018953,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-15T20:05:45.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":110000,"price":0.51,"value":56100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer.  The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":2534847,"source":{"system":"sec-edgar","filing":"0001477932-25-007588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007588/form4.xml","form_type":"4"}},{"id":1018952,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-10-15T20:05:33.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":96153,"price":0.01,"value":961.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer.  The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":96153,"derivative":{"exercise_price":0.6,"exercise_date":"2025-10-14","expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":96153},"source":{"system":"sec-edgar","filing":"0001477932-25-007587","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007587/form4.xml","form_type":"4"}},{"id":1018951,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:05:33.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":96153,"price":0.51,"value":49038.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer.  The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":1062967,"source":{"system":"sec-edgar","filing":"0001477932-25-007587","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007587/form4.xml","form_type":"4"}},{"id":1018950,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68971,"kind":"person","name":"STILL TIMOTHY I","position":1,"cik":"0001200616","reported_name":"STILL TIMOTHY I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-10-15T20:05:10.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":48076,"price":0.01,"value":480.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":48076,"derivative":{"exercise_price":0.6,"exercise_date":"2025-10-14","expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":48076},"source":{"system":"sec-edgar","filing":"0001477932-25-007585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007585/form4.xml","form_type":"4"}},{"id":1018949,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68971,"kind":"person","name":"STILL TIMOTHY I","position":1,"cik":"0001200616","reported_name":"STILL TIMOTHY I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:05:10.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":48076,"price":0.51,"value":24518.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant."}],"balance_after":1535458,"source":{"system":"sec-edgar","filing":"0001477932-25-007585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007585/form4.xml","form_type":"4"}},{"id":1022732,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:48.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":6110,"price":0.648,"value":3959.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":148172,"source":{"system":"sec-edgar","filing":"0001477932-25-007406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007406/form4.xml","form_type":"4"}},{"id":1022731,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:47.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5834,"price":0.648,"value":3780.432,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":326451,"source":{"system":"sec-edgar","filing":"0001477932-25-007405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007405/form4.xml","form_type":"4"}},{"id":1022730,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:42.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4620,"price":0.648,"value":2993.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":140455,"source":{"system":"sec-edgar","filing":"0001477932-25-007404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007404/form4.xml","form_type":"4"}},{"id":1022729,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:41.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5389,"price":0.648,"value":3492.072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":155535,"source":{"system":"sec-edgar","filing":"0001477932-25-007403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007403/form4.xml","form_type":"4"}},{"id":1022728,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:26.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":8146,"price":0.648,"value":5278.608,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,333 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":199731,"source":{"system":"sec-edgar","filing":"0001477932-25-007402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007402/form4.xml","form_type":"4"}},{"id":1022727,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74483,"kind":"person","name":"Michel Gaetan","position":1,"cik":"0001709503","reported_name":"Michel Gaetan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:18.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":12333,"price":0.648,"value":7991.784,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 24,666 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":256746,"source":{"system":"sec-edgar","filing":"0001477932-25-007401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007401/form4.xml","form_type":"4"}},{"id":1022726,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:15.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5850,"price":0.648,"value":3790.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":393089,"source":{"system":"sec-edgar","filing":"0001477932-25-007400","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007400/form4.xml","form_type":"4"}},{"id":1031002,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-09-30T20:02:03.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4158,"price":0.605,"value":2515.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,900 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":145075,"source":{"system":"sec-edgar","filing":"0001477932-25-007233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007233/form4.xml","form_type":"4"}},{"id":1031000,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-09-30T20:02:00.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5230,"price":0.605,"value":3164.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 19,125 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":332285,"source":{"system":"sec-edgar","filing":"0001477932-25-007232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007232/form4.xml","form_type":"4"}},{"id":1031001,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-09-30T20:01:49.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5568,"price":0.605,"value":3368.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,375 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":398939,"source":{"system":"sec-edgar","filing":"0001477932-25-007231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007231/form4.xml","form_type":"4"}},{"id":1030999,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-09-30T20:01:29.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5604,"price":0.605,"value":3390.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,925 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":154282,"source":{"system":"sec-edgar","filing":"0001477932-25-007230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007230/form4.xml","form_type":"4"}},{"id":1030998,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74483,"kind":"person","name":"Michel Gaetan","position":1,"cik":"0001709503","reported_name":"Michel Gaetan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-30T20:01:27.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":11362,"price":0.605,"value":6874.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 22,725 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":369079,"source":{"system":"sec-edgar","filing":"0001477932-25-007229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007229/form4.xml","form_type":"4"}},{"id":1030997,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-30T20:01:10.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5503,"price":0.605,"value":3329.315,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,725 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":160924,"source":{"system":"sec-edgar","filing":"0001477932-25-007228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007228/form4.xml","form_type":"4"}},{"id":1041059,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-15T13:00:07.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.659,"value":9885.0,"ownership":{"direct":true},"balance_after":2624847,"source":{"system":"sec-edgar","filing":"0001477932-25-006725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006725/form4.xml","form_type":"4"}},{"id":1063248,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:32.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":26143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 26,143 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 13,072 units and 13,071 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":533770,"source":{"system":"sec-edgar","filing":"0001477932-25-006103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006103/form4.xml","form_type":"4"}},{"id":1063246,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:24.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 27,400 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 13,700 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":159886,"source":{"system":"sec-edgar","filing":"0001477932-25-006102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006102/form4.xml","form_type":"4"}},{"id":1063245,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:17.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":15223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 15,223 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 7,612 units and 7,611 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":149233,"source":{"system":"sec-edgar","filing":"0001477932-25-006101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006101/form4.xml","form_type":"4"}},{"id":1063244,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:06.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":33991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 33,991 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 16,996 units and 16,995 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":337515,"source":{"system":"sec-edgar","filing":"0001477932-25-006100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006100/form4.xml","form_type":"4"}},{"id":1063243,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:00.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":19524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 19,524 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 9,762 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":151156,"source":{"system":"sec-edgar","filing":"0001477932-25-006099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006099/form4.xml","form_type":"4"}},{"id":1063242,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-08-19T20:05:51.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":24031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 24,031 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 12,016 units and 12,015 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":207877,"source":{"system":"sec-edgar","filing":"0001477932-25-006098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006098/form4.xml","form_type":"4"}},{"id":1063241,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64387,"kind":"person","name":"Rubin Ethel","position":1,"cik":"0002038290","reported_name":"Rubin Ethel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:45.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":17424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 17,424 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":62948,"source":{"system":"sec-edgar","filing":"0001477932-25-006097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006097/form4.xml","form_type":"4"}},{"id":1063240,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64383,"kind":"person","name":"Nguyen Kim","position":1,"cik":"0001852492","reported_name":"Nguyen Kim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:38.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":17424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 17,424 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":115816,"source":{"system":"sec-edgar","filing":"0001477932-25-006096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006096/form4.xml","form_type":"4"}},{"id":1063239,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2025-08-19T20:05:16.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":12507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 12,507 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 6,254 units and 6,253 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":203614,"source":{"system":"sec-edgar","filing":"0001477932-25-006095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006095/form4.xml","form_type":"4"}},{"id":1063238,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:05:12.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":9727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 9,727 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 4,864 units and 4,863 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":166427,"source":{"system":"sec-edgar","filing":"0001477932-25-006094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006094/form4.xml","form_type":"4"}},{"id":1073707,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-06T13:00:21.000Z","date":"2025-08-05","kind":"purchase","planned":false,"acquired":true,"shares":78125,"price":0.64,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx."}],"balance_after":966814,"source":{"system":"sec-edgar","filing":"0001477932-25-005495","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005495/form4.xml","form_type":"4"}},{"id":1073705,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-06T13:00:10.000Z","date":"2025-08-05","kind":"purchase","planned":false,"acquired":true,"shares":78125,"price":0.64,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx."}],"balance_after":2609847,"source":{"system":"sec-edgar","filing":"0001477932-25-005494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005494/form4.xml","form_type":"4"}},{"id":1075696,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:48.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6393,"price":0.64,"value":4091.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 23,377 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":303524,"source":{"system":"sec-edgar","filing":"0001477932-25-005474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005474/form4.xml","form_type":"4"}},{"id":1075695,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:41.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6142,"price":0.64,"value":3930.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,069 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":131632,"source":{"system":"sec-edgar","filing":"0001477932-25-005473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005473/form4.xml","form_type":"4"}},{"id":1075694,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:30.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8620,"price":0.64,"value":5516.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 18,341 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":132486,"source":{"system":"sec-edgar","filing":"0001477932-25-005472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005472/form4.xml","form_type":"4"}},{"id":1075693,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:25.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4451,"price":0.64,"value":2848.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,086 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":183846,"source":{"system":"sec-edgar","filing":"0001477932-25-005471","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005471/form4.xml","form_type":"4"}},{"id":1075692,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:15.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2766,"price":0.64,"value":1770.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 6,690 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":156700,"source":{"system":"sec-edgar","filing":"0001477932-25-005470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005470/form4.xml","form_type":"4"}},{"id":1075691,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:08.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4279,"price":0.64,"value":2738.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 10,190 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":134010,"source":{"system":"sec-edgar","filing":"0001477932-25-005469","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005469/form4.xml","form_type":"4"}},{"id":1081715,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-25T20:01:29.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received 100,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $2.50 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to July 24, 2028, which date shall be no earlier than July 24, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all."}],"balance_after":507627,"source":{"system":"sec-edgar","filing":"0001477932-25-005251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005251/form4.xml","form_type":"4"}},{"id":1081714,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-25T20:01:15.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received 200,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $2.50 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to July 24, 2028, which date shall be no earlier than July 24, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all."}],"balance_after":2531722,"source":{"system":"sec-edgar","filing":"0001477932-25-005250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005250/form4.xml","form_type":"4"}},{"id":1093772,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC - Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-07-03T17:06:03.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5417,"price":0.7679,"value":4159.7143,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,527 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":188297,"source":{"system":"sec-edgar","filing":"0001477932-25-004917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004917/form4.xml","form_type":"4"}},{"id":1093771,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:53.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3066,"price":0.7679,"value":2354.3814,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,302 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":138289,"source":{"system":"sec-edgar","filing":"0001477932-25-004916","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004916/form4.xml","form_type":"4"}},{"id":1093770,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:44.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1996,"price":0.7679,"value":1532.7284,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 4,828 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":159466,"source":{"system":"sec-edgar","filing":"0001477932-25-004915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004915/form4.xml","form_type":"4"}},{"id":1093768,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64385,"kind":"person","name":"Batchelor Ann-Louise","position":1,"cik":"0001945612","reported_name":"Batchelor Ann-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:35.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6177,"price":0.7679,"value":4743.3183,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,143 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":141106,"source":{"system":"sec-edgar","filing":"0001477932-25-004914","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004914/form4.xml","form_type":"4"}},{"id":1093769,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:24.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4462,"price":0.7679,"value":3426.3698,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,871 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":309917,"source":{"system":"sec-edgar","filing":"0001477932-25-004913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004913/form4.xml","form_type":"4"}},{"id":1093767,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:14.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4401,"price":0.7679,"value":3379.5279,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,365 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":137774,"source":{"system":"sec-edgar","filing":"0001477932-25-004912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004912/form4.xml","form_type":"4"}},{"id":1110611,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64386,"kind":"person","name":"Reynolds Cameron John","position":1,"cik":"0001340610","reported_name":"Reynolds Cameron John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-06-16T12:27:54.000Z","date":"2025-06-12","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":0.5898,"value":7372.5,"ownership":{"direct":true},"balance_after":2331722,"source":{"system":"sec-edgar","filing":"0001477932-25-004603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004603/form4.xml","form_type":"4"}},{"id":1123893,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64381,"kind":"person","name":"Innes Guy Archibald","position":1,"cik":"0001579377","reported_name":"Innes Guy Archibald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T11:55:21.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.5386,"value":10772.0,"ownership":{"direct":true},"balance_after":888689,"source":{"system":"sec-edgar","filing":"0001477932-25-004394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004394/form4.xml","form_type":"4"}},{"id":1126744,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2025-06-03T20:07:04.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":8327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 8,327 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,776 units, 2,776 units, and 2,775 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":191107,"source":{"system":"sec-edgar","filing":"0001477932-25-004375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004375/form4.xml","form_type":"4"}},{"id":1126743,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64383,"kind":"person","name":"Nguyen Kim","position":1,"cik":"0001852492","reported_name":"Nguyen Kim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:06:49.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":11983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 11,983 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,995 units, 3,994 units, and 3,994 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":98392,"source":{"system":"sec-edgar","filing":"0001477932-25-004374","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004374/form4.xml","form_type":"4"}},{"id":1126742,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57267,"kind":"person","name":"Plummer Nicholas","position":1,"cik":"0001880653","reported_name":"Plummer Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, Volition Diagnostics"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:39.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":16086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 16,086 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 5,362 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":193714,"source":{"system":"sec-edgar","filing":"0001477932-25-004373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004373/form4.xml","form_type":"4"}},{"id":1126741,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":74483,"kind":"person","name":"Michel Gaetan","position":1,"cik":"0001709503","reported_name":"Michel Gaetan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:17.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7835,"price":0.503,"value":3941.005,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,671 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":380441,"source":{"system":"sec-edgar","filing":"0001477932-25-004372","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004372/form4.xml","form_type":"4"}},{"id":1126740,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:08.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6408,"price":0.503,"value":3223.224,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,258 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":141355,"source":{"system":"sec-edgar","filing":"0001477932-25-004370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004370/form4.xml","form_type":"4"}},{"id":1126739,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57268,"kind":"person","name":"Rootsaert Rodney Gerard","position":1,"cik":"0001577894","reported_name":"Rootsaert Rodney Gerard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:08.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":10190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 10,190 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,397 units, 3,397 units, and 3,396 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":147763,"source":{"system":"sec-edgar","filing":"0001477932-25-004370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004370/form4.xml","form_type":"4"}},{"id":1126738,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:06.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11683,"price":0.503,"value":5876.549,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 35,783 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":314379,"source":{"system":"sec-edgar","filing":"0001477932-25-004371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004371/form4.xml","form_type":"4"}},{"id":1126737,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:06.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":23377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 23,377 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 7,793 units, 7,792 units, and 7,792 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":326062,"source":{"system":"sec-edgar","filing":"0001477932-25-004371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004371/form4.xml","form_type":"4"}},{"id":1126736,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57270,"kind":"person","name":"Forterre Gael","position":1,"cik":"0001841637","reported_name":"Forterre Gael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:00.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4234,"price":0.503,"value":2129.702,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 10,240 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":161462,"source":{"system":"sec-edgar","filing":"0001477932-25-004369","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004369/form4.xml","form_type":"4"}}],"next_cursor":"2025-06-03T20:06:00.000000Z,1126736"}